Bioequivalence Study to Compare Selexipag 400 Microgram Film Coated Tablets Versus Uptravi® (Selexipag) 400 Microgram Film Coated Tablets

Clinical trial NCT07694128 · COMPLETED

Trial details

NCT number: NCT07694128
Sponsor: Humanis Saglık Anonim Sirketi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Arterial Hypertension (PAH)

Start date: 2026-04-08
Primary completion: 2026-06-16
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.